New Drug for Cushing's?

[Pituitary Chat]

New Message on Pituitary Chat New Drug for Cushing's? Reply   Recommend Message 1 in Discussion From: PTResearcher2 Check out the two uses for this drug...   Mifepristone Orphan Drug Status for Cushing's Syndrome Secondary to ACTH Secretion in EU On July 27, the European Commission approved orphan drug status for mifepristone (made by Laboratoire HRA Pharma, France) in the treatment of Cushing's syndrome secondary to ectopic adrenocorticotrophic hormone (ACTH) secretion. The condition affects fewer than 5,000 individuals in the European Union (EU). The product acts as a reversible competitive antagonist at cortisol receptors, thereby decreasing the effects of elevated cortisol levels and improving long-term outcome. Mifepristone (made by HRA Pharma) was approved for this orphan drug indication by the U.S. Food and Drug Administration (FDA) in February 2005. Mifepristone was also granted traditional approval by the FDA in September 2000 for the medical termination of intrauterine pregnancies. http://www.medscape.com/viewarticle/512621 View other groups in this category. Also on MSN: Start Chatting | Listen to Music | House & Home | Try Online Dating | Daily Horoscopes To stop getting this e-mail, or change how often it arrives, go to your E-mail Settings. Need help? If you've forgotten your password, please go to Passport Member Services. For other questions or feedback, go to our Contact Us page. If you do not want to receive future e-mail from this MSN group, or if you received this message by mistake, please click the "Remove" link below. On the pre-addressed e-mail message that opens, simply click "Send". Your e-mail address will be deleted from this group's mailing list. Remove my e-mail address from Pituitary Chat.